Bristol Pravachol 80 Mg Long-Term Safety Data Is Phase IV Commitment

FDA is requesting long-term safety information on the 80 mg and 160 mg strengths of Bristol-Myers Squibb's Pravachol (pravastatin) as a postmarketing commitment associated with the agency's approval of Pravachol 80 mg